Fine mapping of low-density lipoprotein receptor gene by genetic linkage on chromosome 19p13.1-p13.3 and study of the founder effect of four French Canadian low-density lipoprotein receptor gene mutations

Atherosclerosis

Volumn 143, Issue 1, 1999, Pages 145-151

  Couture, Patrick ^a   Morissette, Jean ^a   Gaudet, Daniel ^b   Vohl, Marie Claude ^a   Gagné, Claude ^a   Bergeron, Jean ^a   Després, Jean Pierre ^a   Simard, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

^b CHICOUTIMI HOSPITAL   (Canada)

Author keywords

Familial hypercholesterolemia; French Canadians; Genetic linkage mapping; LDLR

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 9P; CLINICAL ARTICLE; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENETIC LINKAGE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL;

ALLELES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; FOUNDER EFFECT; FRANCE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LINKAGE (GENETICS); LOD SCORE; MICROSATELLITE REPEATS; MUTATION; POLYMORPHISM, GENETIC; QUEBEC; RECEPTORS, LDL;

EID: 0033056728     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00267-6     Document Type: Article

References (37)

1. Goldstein J.L., Hobbs H.H., Brown M.S. Familial hypercholesterolemia. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Basis of Inherited Diseases. 1995;1981-2030 McGraw-Hill, New York.
2. Moorjani S., Roy M., Gagné C., Davignon J., Brun D., Toussaint M., Lambert M., Campeau L., Blaichman S., Lupien P. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis. 9:1989;211-216.
3. Hobbs H.H., Brown M.S., Russell D.W., Davignon J., Goldstein J.L. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N. Engl. J. Med. 317:1987;734-737.
4. Ma Y.H., Bétard C., Roy M., Davignon J., Kessling A.M. Identification of a second 'French Canadian' LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin. Genet. 36:1989;219-228.
5. Simard J., Moorjani S., Vohl M.C., Couture P., Torres A.L., Gagné C., Després J.P., Labrie F., Lupien P.J. Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians. Hum. Mol. Genet. 3:1994;1689-1691.
6. Couture P, Vohl MC, Gagné C, Gaudet D, Torres AL, Lupien PJ, Després JP, Labrie F, Simard J, Moorjani S. Identification of three mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians. Hum Mutat 1998; Suppl 1:S226-231.
7. Assouline L., Leitersdorf E., Lambert M., Reshef A., Feoli-Fonseca J.C., Levy E. Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: mutational analysis and biochemical studies. Hum. Mutat. 9:1997;555-562.
8. Vohl M., Couture P., Moorjani S., Torres A., Gagné C., Després J., Lupien P., Labrie F., Simard J. Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians. Hum. Mutat. 6:1995;243-246.
9. Moorjani S., Gagné C., Lupien P.J., Brun D. Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia. Metabolism. 35:1986;311-316.
10. Sambrook J., Fritsh E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor, New York.
11. Hobbs H.H., Esser V., Russell D.W. AvaII polymorphism in the human LDL receptor gene. Nucleic. Acids. Res. 15:1987;379.
12. Dausset J., Cann H., Cohen D., Lathrop M., Lalouel J., White R. Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics. 6:1990;575-577.
13. Dib C., Faure S., Fizames C., Samson D., Drouot N., Vignal A., Millasseau P., Marc S., Hazan J., Seboun E., Lathrop M., Gyapay G., Morissette J., Weissenbach J. A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature. 380:1996;152-154.
14. Lathrop G.M., Lalouel J.M. Easy calculations of lod scores and genetic risks on small computers. Am. J. Hum. Genet. 36:1984;460-465.
15. Morissette J., Rhéaume E., Leblanc J.F., Luu-The V., Labrie F., Simard J. Genetic linkage mapping of HSD3B1 and HSD3B2 encoding human types I and II 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase close to D1S514 and the centromeric D1Z5 locus. Cytogenet. Cell. Genet. 69:1995;59-62.
16. Durocher F., Morissette J., Labrie Y., Labrie F., Simard J. Mapping of the HSD17B2 gene encoding type II 17 beta-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2. Genomics. 25:1995;724-726.
17. Lathrop M., Nakamura Y., Cartwright P., O'Connell P., Leppert M., Jones C., Tateishi C., Bragg T., Lalouel J.M., White R. A primary genetic map of markers on chromosome 10. Genomics. 2:1988;157-164.
18. Lathrop G.M., Lalouel J.M. Statistical methods for linkage analysis. Rao C.R., Chakravarty R. Handbook of statistics. 1991;81-123 Elsevier Science Publishers, Amsterdam.
19. Lindgren V., Luskey K.L., Russell D.W., Francke U. Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes. Proc. Natl. Acad. Sci. USA. 82:1985;8567-8571.
20. Day I.N., Haddad L., O'Dell S.D., Day L.B., Whittall R.A., Humphries S.E. Identification of a common low density lipoprotein receptor mutation (R329X) in the south of England: complete linkage disequilibrium with an allele of microsatellite D19S394. J. Med. Genet. 34:1997;111-116.
21. Hegele R.A., Plaetke R., Lalouel J.M. Linkage disequilibrium between DNA markers at the low-density lipoprotein receptor gene. Genet. Epidemiol. 7:1990;69-81.
22. Leitersdorf E., Chakravarti A., Hobbs H.H. Polymorphic DNA haplotypes at the LDL receptor locus. Am. J. Hum. Genet. 44:1989;409-421.
23. Vohl M.C., Moorjani S., Roy M., Gaudet D., Torres A.L., Minnich A., Gagné C., Tremblay G., Lambert M., Bergeron J., Couture P., Perron P., Blaichman S., Brun L.D., Davignon J., Lupien P.J., Després J.P. Geographic distribution of French-Canadian low-density lipoprotein receptor gene mutations in the Province of Quebec. Clin. Genet. 52:1997;1-6.
24. Davignon J., Roy M. Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a 'founder effect'. Am. J. Cardiol. 72:1993;6-10.
25. Jomphe M., Bouchard G., Davignon J., De Braekeler M., Gradie M., Kessling A., Laberge C., Moorjani S., Morgan K., Roy M., Scriver C. Familial hypercholesterolemia in French-Canadians: geographical distribution and centre of origin of an LDL-receptor deletion mutation. Am. J. Hum. Genet. 43:1988;A216.
26. Bétard C., Kessling A.M., Roy M., Chamberland A., Lussier-Cacan S., Davignon J. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians. Hum. Genet. 88:1992;529-536.
27. Leitersdorf E., Tobin E.J., Davignon J., Hobbs H.H. Common low-density lipoprotein receptor mutations in the French Canadian population. J. Clin. Invest. 85:1990;1014-1023.
28. Jensen H.K., Jensen L.G., Hansen P.S., Faergeman O., Gregersen N. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin. Chem. 42:1996;1140-1146.
29. Hobbs H.H., Brown M.S., Goldstein J.L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1:1992;445-466.
30. Kotze M.J., Langenhoven E., Warnich L., du Plessis L., Retief A.E. The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners. Ann. Hum. Genet. 55:1991;115-121.
31. Seftel H.C., Baker S.G., Jenkins T., Mendelsohn D. Prevalence of familial hypercholesterolemia on Johannesburg Jews. Am. J. Med. Genet. 34:1989;545-547.
32. Lehrman M.A., Schneider W.J., Brown M.S., Davis C.G., Elhammer A., Russell D.W., Goldstein J.L. The Lebanese allele at the low density lipoprotein receptor locus: nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. J. Biol. Chem. 262:1987;401-410.
33. Aalto-Setala K., Koivisto U.M., Miettinen T.A., Gylling H., Kesaniemi Y.A., Savolainen M., Pyorala K., Ebeling T., Mononen I., Turtola H., Viikari J., Kontula K. Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland. J. Intern. Med. 231:1992;227-234.
34. Slimane M.N., Pousse H., Maatoug F., Hammami M., Ben-Farhat M.H. Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia. Atherosclerosis. 104:1993;153-158.
35. Graadt van Roggen F., van der Westhuyzen D.R., Marais A.D., Gevers W., Coetzee G.A. Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas. Hum. Genet. 88:1991;204-208.
36. Meiner V., Landsberger D., Berkman N., Reshef A., Segal P., Seftel H.C., Van der Westhuyzen D.R., Jeenah M.S., Coetzee G.A., Leitersdorf E. A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews. Am. J. Hum. Genet. 49:1991;443-449.
37. Koivisto U.M., Hamalainen L., Taskinen M.R., Kettunen K., Kontula K. Prevalence of familial hypercholesterolemia among young north Karelian patients with coronary heart disease: a study based on diagnosis by polymerase chain reaction. J. Lipid. Res. 34:1993;269-277.